‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Art of Investment
Biotech investing, mRNA and genome editing with Dr Daniel Koller, Portfolio Manager at Bellevue Asset Management
30
00:00:00
/ 00:35:01
30